Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEqtec Regulatory News (EQT)

  • There is currently no data for EQT

Exercise of warrants

5 Jan 2021 07:00

RNS Number : 5159K
EQTEC PLC
05 January 2021
 

5 January 2021

 

EQTEC plc

("EQTEC", the "Company" or the "Group")

 

Exercise of warrants

Total Voting Rights

 

EQTEC plc (AIM: EQT), a world leading gasification technology solutions company for sustainable waste-to-energy projects, announces the exercise of certain warrants to subscribe for new ordinary shares in the Company ("New Ordinary Shares").

 

Exercise of warrants

 

Warrants over 12,000,000 New Ordinary Shares at a price of 0.25 pence per share and warrants over 30,773,543 New Ordinary Shares at a price of 0.33 pence per share have been exercised. The aggregate gross proceeds of these exercises receivable by the Company amount to ÂŁ131,553.

 

Admission and Total Voting Rights

 

The Company will make an application to the London Stock Exchange plc for the 42,773,543 New Ordinary Shares, to be issued and allotted as a result of the warrant exercises set out above, to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings will commence on or around 8 January 2021. The 42,773,543 New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following Admission, there will be 7,027,485,849 Ordinary Shares in issue. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

ENQUIRIES

EQTEC plc

+353 21 2409 056

David Palumbo / Gerry Madden

Strand Hanson - Nomad & Financial Adviser

+44 20 7409 3494

James Harris / James Dance / Jack Botros

Arden Partners - Broker

+44 20 7614 5900

Paul Shackleton (Corporate) / Simon Johnson (Sales)

Maitland/AMO - Strategic Communications & PR/IR adviser

+44 20 7379 5151

James Benjamin

James.benjamin@maitland.co.uk

 

About EQTEC plc

EQTEC is a world leading advanced gasification technology partner with proven proprietary patented technology for waste-to-value applications.

 

EQTEC designs and supplies advanced gasification solutions that have a higher efficiency product offering and are modular and scalable from 1MW to 25MW. EQTEC's versatile solutions are independently proven to process over 50 different types of feedstock, including municipal waste, agricultural waste, biomass and plastics with no hazardous waste or toxic emissions. EQTEC's solutions produce a uniquely pure high-quality synthesis gas (syngas), that is capable of being used for the widest applications in the creation of energy, hydrogen and biofuels.

 

Proprietary technology design together with deployment and maintenance capabilities mitigate the risks when using third party equipment. EQTEC's Technology Integration capabilities enable the Group to lead collaborative ecosystems that build sustainable, waste elimination and green energy infrastructure.

 

The Company is quoted on AIM (ticker: EQT) and the London Stock Exchange awarded EQTEC the Green Economy Mark that recognises listed companies with 50% or more of revenues from environmental/green solutions.

 

Further information on the Company can be found at www.eqtec.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAPFLEFAFEFA
Date   Source Headline
25th Feb 20263:55 pmRNSChange of Name
25th Feb 20267:00 amRNSHigh-Grade Copper and Gold Potential at Green Rock
23rd Feb 20267:00 amRNSFacility Conversion Notice and Cancellation
16th Feb 20263:13 pmRNSCompletion of Proposals
12th Feb 20263:04 pmRNSResult of Extraordinary General Meeting
29th Jan 20267:33 amRNSPlacing, Debt Restructure and Acquisition
21st Jan 20267:00 amRNSPublication of Circular and Notice of EGM
14th Jan 20265:30 pmRNSFacility Conversion Notice
14th Jan 20267:00 amRNSComplementary strategic expansion
23rd Dec 202511:45 amRNSDrawdown and Funding Update
15th Dec 20253:38 pmRNSFacility Conversion Notice
11th Dec 20256:02 pmRNSFacility Conversion Notice
9th Dec 20257:00 amRNSHoldings in Company
3rd Dec 20258:14 amRNSProject Funding Update: France
24th Nov 202512:30 pmRNSCorporate and Funding Update
7th Nov 20254:35 pmRNSFacility Conversion Notice
24th Oct 20257:00 amRNSCompany update, Board changes and Funding
6th Oct 20257:00 amRNSUltimate Beneficial Owner Notification
29th Sep 20257:00 amRNSInterim Results
25th Sep 20256:00 pmRNSResult of Annual General Meeting
29th Aug 20257:00 amRNSProposed Capital Reorganisation and Notice of AGM
11th Aug 202510:37 amRNSExercise of Option & Subscription of £250k
25th Jun 20251:27 pmRNSResults of EGM
2nd Jun 20257:00 amRNSPublication of Circular and Notice of EGM
10th Apr 20257:00 amRNS£1.5m Subscription and Loan Transfer
15th Nov 20248:10 amRNSDisposal of MetalNRG Shares
15th Nov 20247:00 amRNSHolding(s) in Company
5th Nov 20247:00 amRNSCollaboration Framework Agreement in the USA
26th Sep 20247:04 amRNSInterim Results
18th Sep 20247:00 amRNSAppointment of Non-executive Director
16th Sep 20247:00 amRNSSenior Management Appointment
12th Sep 20247:00 amRNSSuccessful steam oxygen gasification test results
9th Sep 20248:03 amRNSResult of WRAP Retail Offer
4th Sep 20247:51 amRNSWRAP Retail Offer for up to £200,000
4th Sep 20247:50 amRNS£1.1m Fundraise, Retail Offer & Debt Conversion
4th Sep 20247:00 amRNSReceipt of funds under Settlement Agreement
14th Aug 20247:00 amRNSUpdate on Settlement Agreement with Logik
9th Aug 20247:00 amRNSTransition of Group COO role
6th Aug 20242:20 pmRNSResults of 2024 AGM
29th Jul 20241:30 pmRNSUpdate on Settlement Agreement with Logik
26th Jul 20247:00 amRNSAcquisition of property housing Italy MDC plant
15th Jul 20247:00 amRNSUpdate on Settlement Agreement with Logik
10th Jul 20247:00 amRNSNotice of AGM
28th Jun 20248:23 amRNSUpdate on Settlement with Logik Developments
28th Jun 20247:00 amRNSFinal Results
26th Jun 202412:22 pmRNSHolding(s) in Company
12th Jun 20244:09 pmRNSHolding(s) in Company
11th Jun 20241:58 pmRNSEquity placement update and total voting rights
31st May 20241:56 pmRNSEquity placement update and total voting rights
28th May 20247:00 amRNSEquity placement of c. £850,000

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.